B. Haley
Biomaterials · with Frenkel · 2004–2008
A researcher in the Science corpus: 2 papers; trusts 1 researcher and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Biomaterials — 7 citations into it; #1,036 of 2,152 by trust here, #1,730 by citations
- Oncology — 7 citations into it
Whom B. Haley trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts B. Haley overall
Papers from B. Haley's perspective
Ordered by how strongly the researchers B. Haley trusts endorse each paper. Same corpus, a different order for every researcher.
- The enhanced permeability and retention (EPR) effect in tumor vasculature: the key role of tumor-selective macromolecular drug targeting. (Advances in Enzyme Regulation)
- Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. (Journal of Clinical Oncology)
- Delivering nanomedicine to solid tumors (Nature Reviews Clinical Oncology)
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile (Science Translational Medicine)
- Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. (Progress in lipid research)
- New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer… (Journal of the National Cancer Institute)
- Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan. (Journal of Clinical Oncology)
- Long-circulating and target-specific nanoparticles: theory to practice. (Pharmacological Reviews)
- Drug Delivery Systems: Entering the Mainstream (Science)
- Nanocrystal targeting in vivo (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- Nanoparticles for drug delivery in cancer treatment. (2008) — 803 citations
- Circulating Tumor Cells in Patients with Breast Cancer Dormancy (2004) — 949 citations